Medicaid Prescription Reimbursement Information by State Quarter Ending June 2010

Similar documents
Business Creation Index

NCSL TABLE REAL ESTATE TRANSFER TAXES

Your Guide to. Real Estate. Customs by State

State Housing Trust Fund Revenues 2017

Your Guide to Real Estate Customs by State

REQUIRED WITNESSES FOR A MORTGAGE OR DEED OF TRUST

No Survey Required w/ Survey. Affidavit. Affidavit. Affidavit

ALI-ABA Course of Study Commercial Lending and Banking Law January 29-31, 2009 Scottsdale, Arizona

Alabama. Alaska. Arizona. Arkansas. California. Colorado

MULTIFAMILY TAX SUBSIDY PROJECT INCOME LIMITS

CBRE INDUSTRIAL & LOGISTICS SPECIAL PROPERTIES GROUP

State Tax Credits for Historic Preservation A State-by-State Summary. States with income tax incentives States that do not tax income

What is Proper Tax Policy for Smokeless Tobacco Products?

SPECIAL PROPERTIES GROUP INDUSTRIAL SERVICES

Administration > Exemption Certificate Validity Periods

Nevada Single Document Rule

The Subject Section. Chapter 2. Property Address

AGRICULTURAL CONSERVATION EASEMENT PROGRAM AGRICULTURAL LAND EASEMENTS

What Is Proper Tax Policy for Smokeless Tobacco Products?

Paper for presentation at the 2005 AAEA annual meeting Providence, RI July 24-27, 2005

TO: Rural Development State Directors

Federal Rental Assistance Provides Affordable Homes for Vulnerable People in All Types of Communities

APPLICATION FOR LEASE OF APARTMENT EQUAL HOUSING OPPORTUNITY

Goomzee Corporation Fall MLS Platforms. America s MLS Platform Vendors & Market Distribution. Goomzee Research

Citizen s Activity Sheet

U.S. Home Price Insights Report

Automatic Renewal Laws in All 50 States Index

Understanding Whom the LIHTC Program Serves

REPORT TO COUNCIL City of Sacramento

I. The Affordability Problem in Boston II. What is Affordable? III.Housing Costs IV.Housing Production V. What Can Public Policy Do? I.

VERMONT S RENTAL HOUSING AFFORDABILITY GAP CONTINUES TO GROW The Average Vermont Renter Can t Afford a Modest 2-Bedroom Apartment

Foreclosures Copyright 2014 Rogue Investor

U.S. Department of Housing and Urban Development Office of Fair Housing and Equal Opportunity. Fair Housing. It s Your Right

Good design makes a difference

Status of State PACE Programs

National Foreclosure Report

Collateral Risk Network Review Panel Discussion

STATUS OF STATE PACE PROGRAMS

National Foreclosure Report

Marijuana and Real Estate: A Budding Issue

District Facilities and Public Charter Schools

The following is a review of the law of land trusts in all fifty states:

More details >>> HERE <<<

Sources Consulted. International Association of Assessing Officers Standard on Ratio Studies (draft version). February.

Testimony on OH HB 323, Foreclosure Reform, November, 2009

State Guide To Tax Lien And Tax Deed Investing

Report on Nevada s Housing Market

U.S. Department of Housing and Urban Development

APPLICATION FOR LEASE OF APARTMENT EQUAL HOUSING OPPORTUNITY

Report on Nevada s Housing Market

More details >>> HERE <<<

Short Sale Guide. The real estate agent faxes the complete Short Sale Package to , Attn: Setup.

Horry County Personal Property Return 2017

Wilcomb E. Washburn Papers,

ABOUT THE UNITED TRUSTEE ASSOCIATION

The Voice of the 1031 Industry

Report on Nevada s Housing Market

Summary of Benefits and Coverage: What this Plan Covers & What You Pay For Covered Services Coverage Period: 08/01/ /31/2018

issues key STATE ADVOCACY

Vertical File Finding Aid 1. Vertical File. Art and Architecture Collection. New York Public Library

Report on Nevada s Housing Market

Tulsa County Public Service Net Values

Report on Nevada s Housing Market

MedicaidEligibility Planning

Steve Leimberg's Asset Protection Planning Newsletter - Archive Message #190 Date: From: Subject:

AN APPRAISAL OF THE MODEL BUSINESS CORPORATION ACT S APPRAISAL RIGHTS PROVISIONS

MASON DIXON RED ANGUS ASSOCIATION

UNCLAIMED PROPERTY & ESCHEATMENT

The U.S. Department of Housing and Urban Development

Volume URL: Chapter Title: Management and Sale of Foreclosed Properties

Report on Nevada s Housing Market

MSSP. Market Segment Specialization Program. Rehabilitation Tax Credit

STATE POLICY SNAPSHOT

CYBER ESTATE PLANNING AND ADMINISTRATION

US GOVERNMENT SALES GUIDE

PLANNING FOR BIODIVERSITY Authorities in State Land Use Laws

State Farmland Preferential Assessment: A Comparative Study

Bexar county appraisal district exemptions

City Housing Trust Fund Revenues 2018

Report on Nevada s Housing Market

Report on Nevada s Housing Market

Florida's Hospital Lien Laws

Gardner Business Review May 2018 Applied economic analysis by the David Eccles School of Business

Report on Nevada s Housing Market

Report on Nevada s Housing Market

Report on Nevada s Housing Market

Report on Nevada s Housing Market

Report on Nevada s Housing Market

Report on Nevada s Housing Market

The Sage Group

Report on Nevada s Housing Market

Case No CATRICE JOHNSON; FELICIA BADON; MONA BLUNTE; TIFFANI BRUMFIELD; BERTHA WILLIAMS; ET AL

Application for Registration United States / Canada Reciprocity

TITLE EXAMINATION STANDARDS: A STATUS REPORT

BEFORE THE PENNSYLVANIA PUBLIC UTILITY COMMISSION WEST PENN POWER COMPANY DOCKET NO. R Direct Testimony of John J.

Report on Nevada s Housing Market

Rural landowner liability for recreational injuries: Myths, perceptions, and realities

Black Knight Home Price Index Report: December Transactions U.S. Home Prices Down 0.1 Percent for the Month; Up 4.5 Percent Year-Over-Year

Report on Nevada s Housing Market

The Brookings Institution Metropolitan Policy Program Bruce Katz, Director

Transcription:

Medicaid Prescription Reimbursement Information by State Quarter Ending June 2010 ASP=average sale price, AWP=average wholesale price, WAC=wholesaler acquisition cost, NH=nursing home, FFS=fee for service S=State maximum allowance cost and FUL=federal upper limit. * Co-pay varies by cost of prescription. ** CMS Approved State Plans or State Source Revised - 6/30/2010 STATE INGREDIENT COST DISPENSING FEE CO-PAYMENT STATE Alabama Ingredient cost is lower of WAC plus 9.2% or AWP minus 10% Dispensing fee is $5.40 Co-payment is $0.50 to Alaska Ingredient cost is AWP minus 5% Dispensing fee is $3.45 to $11.46 (based on Co-payment is $2.00 pharmacy/medicaid volume) Arizona Ingredient cost is AWP minus 15% Dispensing fee is $2.00 (FFS only) Ingredient cost is AWP minus 20% (generic); Dispensing fee is $5.51 Co-payment is $0.50 to Arkansas California Colorado Connecticut AWP minus 14% (brand) Ingredient cost is AWP minus 17% Dispensing fee is $7.25; $8.00 (legend drugs dispensed to residents in skilled nursing facilities or intermediate care facilities) Ingredient cost is lower of AWP minus 45% (generic); AWP minus 14.5% (brand); Direct Price plus 18%; AWP minus 12% (approved rural ) Ingredient cost is AWP minus 40% (selected multi-source brand and generic); AWP minus 14% (brand) Dispensing fee is $4.00 (retail pharmacy); $1.89 (institutional pharmacy) Dispensing fee is $3.15** 1

Delaware Ingredient cost is AWP minus 14% (traditional, retail independent & retail chain pharmacies); Dispensing fee is $3.65 Co-payment is $0.50 to $3.00 AWP minus 16% (non-traditional, long term care & specialty pharmacies) District of Ingredient cost is AWP minus 10% Dispensing fee is $4.50 Columbia Florida Georgia Ingredient cost is lower of AWP minus 16.4% or WAC plus 4.75% Ingredient cost is AWP minus 11%; Maximum allowable reimbursement for an injectable drug administered by a provider or their designee in an outpatient setting is Average Sales Price (ASP) plus 6% as determined on January 1 st of the applicable year Dispensing fee is $3.73 (for non 340B billed drugs); $7.50 (340B billed drugs) Dispensing fee is $4.63 (for profit pharmacy); $4.33 (not for profit) Co-payment for certain beneficiaries is 2.5% of payment up to $300, capped at 5% of total family income Co-payment is $0.50 to $3.00 Hawaii Ingredient cost is AWP minus 10.5% Dispensing fee is $4.67 Idaho Ingredient cost is AWP minus 12% Dispensing fee is $4.94; $5.54 (unit dose) Illinois Ingredient cost is AWP minus 25% (generic); AWP minus 12% (brand) Dispensing fee is $4.60 (generic); $3.40 (brand) Co-payment is $3.00 (brand only) Indiana Ingredient cost is AWP minus 16% (brand); AWP minus 20% (generic) Dispensing fee is $4.90 Co-payment is $3.00 Iowa Ingredient cost is AWP minus 12% Dispensing fee is $4.57 (nonpreferred brand) (no more than $25.00), $2.00 (nonpreferred brand) (between $25.01 and $50.00), $3.00 (non-preferred brand) ($50.01 or more) Kansas Ingredient cost is AWP minus 27% (generic); AWP minus 13% (brand) Dispensing fee is $3.40 Co-payment is $3.00 2

Kentucky Ingredient cost is AWP minus 14% (generic); AWP minus 15% (brand) Dispensing fee is $5.00 (generic); $4.50 (brand) Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Ingredient cost is AWP minus 13.5% (independent pharmacies); AWP minus 15% (chain pharmacies) Ingredient cost is AWP minus 15%; AWP minus 17% ( direct supply); AWP minus 20% (mail order) Ingredient cost is lower of AWP minus 12%, WAC plus 8%, direct price plus 8% or distributor price when available Ingredient cost is WAC plus 5% (all drugs except 340B billed drugs); actual acquisition cost (340B billed drugs) Ingredient cost is AWP minus 13.5% (independent pharmacy (1 to 4 stores); AWP minus 15.1% (chain pharmacies (5+ stores) Dispensing fee is $5.77** Dispensing fee is $3.35; $1.00 (mail order); $4.35 and $5.35 (compounding); $12.50 (filling insulin syringe) Dispensing fee is $3.69 (generic); $2.69 (brand); $4.69 (generic to NH); $3.69 (brand to NH); $7.25 (home IV therapy) Dispensing fee is $3.00 (all drugs except 340B billed drugs); $10 (340B billed drugs) Dispensing fee is $2.75; $3.00 (long term care) Ingredient cost is AWP minus 12% Dispensing fee is $3.65 (+$0.30 for legend unit dose drugs) Ingredient cost is lower of AWP minus 12% or Dispensing fee is $3.91 (brand); WAC plus 9% (brand); AWP minus 25% $5.50 (generic) (generic) Ingredient cost is lower of AWP minus 10.43% Dispensing fee is $4.09 or WAC plus 10% Ingredient cost is AWP minus 15% Dispensing fee is $5.04 ; $12.50 to $22.50 (compounding) Ingredient cost is AWP minus 11% Dispensing fee is $3.27 to $5.00 (based on service delivery, unit dosage or 3 rd party payors)** (generic or atypical anti-psychotic); $2.00 (brand without generic equivalent); $3.00 (nonpreferred brand); cap $225 per year per recipient Co-payment is $0.50 to Co-payment is $3.00 (not to exceed $30 per month) s for mail order (generic and preferred brand); $3.00 (non-preferred brand) Co payment is $1.00 (multiple source and OTC); $3.00 (all other drugs) Co-payment is $3.00 (medically needy only) Co-payment is $0.50 to $2.00* Co-payment is $2.00 3

Nevada New Hampshire New Jersey New Mexico New York rth Carolina rth Dakota Ohio Oklahoma Ingredient cost is AWP minus 15% Dispensing fee is $4.76; $22.40 daily (home IV therapy); $16.80 daily (nursing facility IV therapy) Ingredient cost is AWP minus 16% Dispensing fee is $1.75 (generic); $2.00 (brand & compound) Ingredient cost is AWP minus 15% Ingredient cost is lower of AWP minus 14%; wholesaler average cost as submitted to State; manufacturer price as submitted to State; pharmacy invoice price as obtained through audits. Ingredient cost is AWP minus 16.25% (brand); AWP minus 25% (generic); AWP minus 12% (specialized HIV pharmacies) Ingredient cost is AWP minus 10%, ASP plus 6.7% (physician administered drugs) Ingredient cost is lower of AWP minus 10% or WAC plus 12.5% Ingredient cost is WAC plus 7% or if WAC cannot be determined, ingredient cost is AWP minus 14.4% Dispensing fee is $3.73 up to $3.99 (twenty-four hour emergency service and impact area location)** Dispensing fee is $3.65 ** Dispensing fee is $4.50 (generic); $3.50 (brand) Dispensing fee is $5.60 (generic); $4.00 (brand) Dispensing fee is $5.60 (generic legend drugs); $4.60 (brand legend drugs); 1.5 times the allowed amount (EAC, FUL, or ) up to a maximum of $4.60 (non-legend drugs that are prescribed; plus $0.15 per pill (pill splitting) Dispensing fee is $3.70 ; $.50 (OTC) Co-payment is $3.00 (brand) Co-payment is $3.00 (non preferred drugs); $2.00 (preferred brand drugs) Ingredient cost is AWP minus 12% Dispensing fee is $4.15 Co payment is $1.00 to $2.00* 4

Oregon Dispensing fee is $3.50 (retail); $3.91 (institutional) Pennsylvania Rhode Island South Carolina South Dakota Tennessee Ingredient cost for multiple source drugs is AWP minus 15%; AWP minus 11% (institutional); AWP minus 68% (mail order); Ingredient cost for single source drugs is AWP minus 15%; AWP minus 11% (institutional); AWP minus 21% (mail order) Ingredient cost is lower of WAC plus 7% or Dispensing fee is $4.00; $5.00 AWP minus 14% (compounding) Ingredient cost is WAC Dispensing fee is $3.40 (outpatient), $2.85 (long term care) Ingredient cost is AWP minus 10% Dispensing fee is $4.05 (independent pharmacy); $3.15 (institutional pharmacies) Ingredient cost is AWP minus 10.5% Dispensing fee is $4.75; $5.55 (unit dose) Ingredient cost is lower of AWP minus 16%, or FUL for Pharmacy Benefit Management (PBM) National Network. Dispensing fee for Pharmacy Benefit Management (PBM) National is $1.50 Dispensing fee for TennCare Ingredient cost is lower of AWP minus 13%, or FUL for TennCare Pharmacy Network. Pharmacy Network is $2.50 (brand); $3.00 (generic); $5.00 (brand nursing home) $6.00 (generic nursing home); $25 Special Pharmacy Rates are set separately (compound prescriptions) Texas Estimated acquisition cost (EAC) is the Dispensing fee is $7.50 plus 2% wholesale estimated acquisition cost ( WEAC), of cost of drug which is the ingredient cost lower of AWP minus 15% or WAC plus12%, or direct estimated acquisition cost (DEAC) for certain drug products available through direct purchasing. Utah Ingredient cost is AWP minus 15% Dispensing fee is $3.90 (urban); $4.40 (rural) Ingredient cost is AWP minus 14.2% Vermont Dispensing fee $4.75 (In-State) $2.50 (Out-of-State) (non preferred generic or generics costing $10.00); copayment (preferred generic & brand); $3.00 (all other brands) Co-payment is $3.00 Co-payment is $3.00 (brand) $0 (generics and Categorically Needy) $3.00 (Medically Needy) ** Co-payment is $3.00 ** to STATE 5

Virginia Ingredient cost is AWP minus 10.25% Dispensing fee is $3.75; $5.00 (unit dose drugs) Washington West Virginia Wisconsin Wyoming Ingredient cost is AWP minus 16% (single source drugs); AWP minus 16% (multi-source drugs with four or fewer manufacturers/labelers); AWP minus 50% (multi-source drugs with five or more manufacturers/labelers and no or FUL) Ingredient cost is AWP minus 15% (brand); AWP minus 30% (generic) Ingredient cost is AWP minus 14% Dispensing fee is $4.24 to $5.25 (based on 3-tiered pharmacy volume) Dispensing fee is $2.50 (brand); $5.30 (generic); $8.25 (340B billed drugs) Dispensing fee is $3.44 (brand); $3.94 (generic); $0.015 per unit (for repackaging); $9.45 to $22.16 (compound drug fee); $9.45 to $40.11 (pharmaceutical Co-payment is $0.50 to Co-payment is $0.50 (overthe-counter); $3.00 (brand); $1.00 (generic); cap $12 per pharmacy per recipient per month care dispensing fee) Ingredient cost is AWP minus 11% Dispensing fee is $5.00 Co-payment is $2.00 6